|
32566.01.01
|
ADAKVEO C/S.SOL.IN 10MG/ML 1 VIAL x10 ml
|
|
1.042,35 |
1.159,31 |
1.290,32 |
Novartis Europharm Ltd
|
|
29097.02.01
|
AFINITOR TAB 10MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC)
|
|
1.662,88 |
1.849,46 |
2.024,14 |
Novartis Europharm Ltd
|
|
29097.03.01
|
AFINITOR TAB 2,5MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC) (ALU/PA/ALU/PVC)
|
|
1.078,18 |
1.199,16 |
1.334,67 |
Novartis Europharm Ltd
|
|
29097.01.01
|
AFINITOR TAB 5MG/TAB BTx30 σε BLISTERS (ALU/PA/ALU/PVC)
|
|
1.173,77 |
1.305,47 |
1.442,61 |
Novartis Europharm Ltd
|
|
31954.02.01
|
AIMOVIG INJ.SOL 140MG/ML BTx1 PF. PENx1 ML
|
|
282,49 |
314,18 |
366,34 |
Novartis Europharm Ltd
|
|
31954.01.01
|
AIMOVIG INJ.SOL 70MG/ML BTx1 PF. PENx1 ML
|
|
283,70 |
315,53 |
367,90 |
Novartis Europharm Ltd
|
|
29403.01.03
|
ARZERRA C/S.SOL.IN 20MG/ML BTx1 VIALx 50ML
|
|
1.776,21 |
1.975,51 |
2.304,88 |
Novartis Europharm Ltd
|
|
29403.01.01
|
ARZERRA C/S.SOL.IN 20MG/ML BTx3 VIALSx 5ML
|
|
558,21 |
620,86 |
750,68 |
Novartis Europharm Ltd
|
|
32461.02.02
|
ATECTURA BREEZHALER INHPD.CAP (125+127.5)MCG/DOSE [(150+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
19,24 |
22,12 |
30,49 |
Novartis Europharm Ltd
|
|
32461.03.02
|
ATECTURA BREEZHALER INHPD.CAP (125+260)MCG/DOSE [(150+320) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
21,10 |
24,25 |
33,42 |
Novartis Europharm Ltd
|
|
32461.01.02
|
ATECTURA BREEZHALER INHPD.CAP (125+62.5)MCG/DOSE [(150+80) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,04 |
20,74 |
28,58 |
Novartis Europharm Ltd
|
|
27919.01.01
|
ATRIANCE SOL.INF 5MG/ML BTx6 VIALS x50 ML
|
|
1.361,23 |
1.513,96 |
1.664,97 |
Novartis Europharm Ltd
|
|
28649.01.01
|
AZARGA EY.DRO.SUS (10+5)MG/ML BTx 1φιαλίδιο (LDPE) x 5ML
|
|
7,19 |
8,27 |
11,40 |
Novartis Europharm Ltd
|
|
24882.01.01
|
AZOPT EY.DRO.SUS 10MG/ML FL X5ML
|
|
3,16 |
3,63 |
5,00 |
Novartis Europharm Ltd
|
|
32460.02.02
|
BEMRIST BREEZHALER INHPD.CAP (125+127.5)MCG/DOSE [(150+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
19,24 |
22,12 |
30,49 |
Novartis Europharm Ltd
|
|
32460.03.02
|
BEMRIST BREEZHALER INHPD.CAP (125+260)MCG/DOSE [(150+320) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
21,10 |
24,25 |
33,42 |
Novartis Europharm Ltd
|
|
32460.01.02
|
BEMRIST BREEZHALER INHPD.CAP (125+62.5)MCG/DOSE [(150+80) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
18,04 |
20,74 |
28,58 |
Novartis Europharm Ltd
|
|
32351.01.01
|
BEOVU INJ.SOL 120MG/ML BTx1 PF.SYRx0.165 ML
|
|
509,27 |
566,41 |
648,42 |
Novartis Europharm Ltd
|
|
27638.03.03
|
COPALIA F.C.TAB (10+160)MG/TAB BTx 28 (σε ΒLISTERS PVC/PVDC)
|
|
6,60 |
7,58 |
10,44 |
Novartis Europharm Ltd
|
|
27638.02.03
|
COPALIA F.C.TAB (5+160)MG/TAB BTx 28 (σε ΒLISTERS PVC/PVDC)
|
|
5,99 |
6,88 |
9,48 |
Novartis Europharm Ltd
|
|
29193.02.02
|
COPALIA HCT F.C.TAB (10+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
9,04 |
10,40 |
14,33 |
Novartis Europharm Ltd
|
|
29193.04.02
|
COPALIA HCT F.C.TAB (10+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
9,19 |
10,57 |
14,56 |
Novartis Europharm Ltd
|
|
29193.05.02
|
COPALIA HCT F.C.TAB (10+320+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
14,73 |
16,94 |
23,34 |
Novartis Europharm Ltd
|
|
29193.01.02
|
COPALIA HCT F.C.TAB (5+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
7,40 |
8,51 |
11,72 |
Novartis Europharm Ltd
|
|
29193.03.02
|
COPALIA HCT F.C.TAB (5+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
8,60 |
9,88 |
13,61 |
Novartis Europharm Ltd
|
|
30996.03.01
|
COSENTYX IN.SO.PF.P 150MG/ML BTx1 Προγεμισμένη συσκευή τύπου πένας x 150mg/ml
|
|
381,90 |
424,74 |
490,75 |
Novartis Europharm Ltd
|
|
30996.03.02
|
COSENTYX IN.SO.PF.P 150MG/ML BTx2 Προγεμισμένες συσκευές τύπου πένας x 150mg/ml
|
|
800,52 |
890,35 |
1.000,40 |
Novartis Europharm Ltd
|
|
30996.02.02
|
COSENTYX INJ.SO.PFS 150MG/ML BTx2 Προγεμισμένες Γυάλινες Σύριγγες x 150mg/ml
|
|
928,99 |
1.033,23 |
1.225,93 |
Novartis Europharm Ltd
|
|
30996.04.03
|
COSENTYX INJ.SOL 300MG/2ML (150MG/ML) 1 PF.PENx2 ML
|
|
763,77 |
849,47 |
954,47 |
Novartis Europharm Ltd
|
|
27247.01.04
|
DUOTRAV EY.DRO.SOL 40μg/ml+5mg/ml BT x 1 BOTTLE (LDPE) x 2,5 ML
|
|
5,11 |
5,87 |
8,09 |
Novartis Europharm Ltd
|
|
27247.01.01
|
DUOTRAV EY.DRO.SOL 40μg/ml+5mg/ml BT x 1 φιάλη x2,5ML
|
|
5,99 |
6,88 |
9,48 |
Novartis Europharm Ltd
|
|
23974.01.01
|
EMADINE EY.DRO.SOL 0,05% FLx5ML
|
|
5,46 |
6,27 |
8,64 |
Novartis Europharm Ltd
|
|
32484.01.02
|
ENERZAIR BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
32484.01.03
|
ENERZAIR BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής+1 αισθητήρας
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
31291.01.01
|
ENTRESTO F.C.TAB (24+26)MG/TAB BTx28
|
|
45,54 |
52,35 |
66,59 |
Novartis Europharm Ltd
|
|
31291.02.02
|
ENTRESTO F.C.TAB (49+51)MG/TAB BTx56
|
|
90,96 |
104,55 |
128,56 |
Novartis Europharm Ltd
|
|
31291.03.02
|
ENTRESTO F.C.TAB (97+103)MG/TAB BTx56
|
|
90,79 |
104,37 |
128,33 |
Novartis Europharm Ltd
|
|
28161.02.03
|
EUCREAS F.C.TAB (50+1000)MG/TAB BT x 60 σε BLIST (PA/AL/PVC/AL)
|
|
16,25 |
18,68 |
25,74 |
Novartis Europharm Ltd
|
|
28161.02.12
|
EUCREAS F.C.TAB (50+1000)MG/TAB BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
22,45 |
25,81 |
35,56 |
Novartis Europharm Ltd
|
|
28161.01.03
|
EUCREAS F.C.TAB (50+850)MG/TAB BT x 60 σε BLIST (PA/AL/PVC/AL)
|
|
21,26 |
24,44 |
33,68 |
Novartis Europharm Ltd
|
|
28161.01.12
|
EUCREAS F.C.TAB (50+850)MG/TAB BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
30,56 |
35,13 |
48,41 |
Novartis Europharm Ltd
|
|
23603.02.01
|
EXELON CAPS 1.5MG/CAP BTx28(BLIST2x14)
|
|
7,34 |
8,43 |
11,62 |
Novartis Europharm Ltd
|
|
23603.03.01
|
EXELON CAPS 3MG/CAP BTx28(BLIST2x14)
|
|
10,56 |
12,13 |
16,72 |
Novartis Europharm Ltd
|
|
23603.04.01
|
EXELON CAPS 4.5MG/CAP BTx28(BLIST2x14)
|
|
12,19 |
14,01 |
19,30 |
Novartis Europharm Ltd
|
|
23603.05.01
|
EXELON CAPS 6MG/CAP BTx28(BLIST2x14)
|
|
12,62 |
14,51 |
19,99 |
Novartis Europharm Ltd
|
|
23603.06.01
|
EXELON ORAL.SOL 2MG/ML FLx120ML
|
|
37,53 |
43,14 |
59,44 |
Novartis Europharm Ltd
|
|
23603.06.02
|
EXELON ORAL.SOL 2MG/ML ΒOTTLEx50 ML+1 δοσομετρική SYR δοσομετρική SYR
|
|
16,08 |
18,48 |
25,46 |
Novartis Europharm Ltd
|
|
23603.09.06
|
EXELON TTS 13,3MG/24h 30 Φακελλίσκοι
|
|
28,46 |
32,72 |
45,09 |
Novartis Europharm Ltd
|
|
23603.09.02
|
EXELON TTS 13,3MG/24h BTx30 SACHETS
|
|
32,91 |
37,83 |
52,13 |
Novartis Europharm Ltd
|
|
23603.07.08
|
EXELON TTS 4,6MG/24h 30 Φακελλίσκοι
|
|
14,46 |
16,63 |
22,92 |
Novartis Europharm Ltd
|
|
23603.07.02
|
EXELON TTS 4,6MG/24h BTx30 SACHETS
|
|
14,61 |
16,79 |
23,14 |
Novartis Europharm Ltd
|
|
23603.08.08
|
EXELON TTS 9,5MG/24h 30 Φακελλίσκοι
|
|
18,66 |
21,45 |
29,56 |
Novartis Europharm Ltd
|
|
23603.08.02
|
EXELON TTS 9,5MG/24h BTx30 SACHETS
|
|
21,57 |
24,80 |
34,17 |
Novartis Europharm Ltd
|
|
27639.03.03
|
EXFORGE F.C.TAB (10+160)MG/TAB BT x 28 σε BLISTERS (PVC/PVDC)
|
|
6,60 |
7,58 |
10,44 |
Novartis Europharm Ltd
|
|
27639.02.03
|
EXFORGE F.C.TAB (5+160)MG/TAB BT x 28 σε BLISTERS (PVC/PVDC)
|
|
5,99 |
6,88 |
9,48 |
Novartis Europharm Ltd
|
|
29194.02.02
|
EXFORGE HCT F.C.TAB (10+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
9,04 |
10,40 |
14,33 |
Novartis Europharm Ltd
|
|
29194.04.02
|
EXFORGE HCT F.C.TAB (10+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
9,19 |
10,57 |
14,56 |
Novartis Europharm Ltd
|
|
29194.05.02
|
EXFORGE HCT F.C.TAB (10+320+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
14,73 |
16,94 |
23,34 |
Novartis Europharm Ltd
|
|
29194.01.02
|
EXFORGE HCT F.C.TAB (5+160+12,5)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
7,40 |
8,51 |
11,72 |
Novartis Europharm Ltd
|
|
29194.03.02
|
EXFORGE HCT F.C.TAB (5+160+25)MG/TAB BTx28 σε BLISTERS PVC/PVDC
|
|
8,60 |
9,88 |
13,61 |
Novartis Europharm Ltd
|
|
27446.05.01
|
EXJADE F.C.TAB 180MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
213,31 |
237,24 |
281,65 |
Novartis Europharm Ltd
|
|
27446.06.01
|
EXJADE F.C.TAB 360MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
422,71 |
470,13 |
543,19 |
Novartis Europharm Ltd
|
|
27446.04.01
|
EXJADE F.C.TAB 90MG/TAB BT x 30 δισκία σε BLISTERS (PVC/PVDC/ALU)
|
|
112,06 |
128,80 |
158,37 |
Novartis Europharm Ltd
|
|
28433.01.04
|
EXTAVIA PS.INJ.SOL 250mcg/ML 15VIALS + 15 PF.SYR x 1,2ML SOLV (οι σύριγγες είναι χωρητικότητας των 2,25ml) x 1,2ML SOLV (οι σύριγγες είναι χωρητικότητας των 2,25ml)
|
|
423,30 |
470,81 |
543,97 |
Novartis Europharm Ltd
|
|
33744.01.02
|
FABHALTA CAPS 200MG/CAP BT X 56 ΚΑΨΑΚΙΑ ΣΕ BLISTER (PVC/PE/PVDC/ALU)
|
|
24.469,09 |
27.214,69 |
29.424,52 |
Novartis Europharm Ltd
|
|
28073.01.03
|
GALVUS TAB 50 MG/TAB BT x 28 σε ΒLISTERS (PA/AL/PVC/AL)
|
|
10,89 |
12,52 |
17,26 |
Novartis Europharm Ltd
|
|
29825.01.03
|
GILENYA CAPS 0,5MG/CAP BTx28 σε BLIST (PVC/PVDC/alu) (PVC/PVDC/alu)
|
|
1.328,99 |
1.478,12 |
1.633,40 |
Novartis Europharm Ltd
|
|
29825.01.05
|
GILENYA CAPS 0,5MG/CAP BTx28 σε BLIST 2x14 (PVC/PVDC/alu)
|
|
920,94 |
1.024,28 |
1.140,02 |
Novartis Europharm Ltd
|
|
25344.03.02
|
GLIVEC F.C.TAB 100MG/TAB BTX60
|
|
333,36 |
370,77 |
432,32 |
Novartis Europharm Ltd
|
|
25344.03.05
|
GLIVEC F.C.TAB 100MG/TAB BTx60 δισκία σε Κυψέλη (PVDC/ALU)
|
|
231,90 |
257,92 |
306,20 |
Novartis Europharm Ltd
|
|
25344.04.02
|
GLIVEC F.C.TAB 400MG/TAB BTX30
|
|
419,22 |
466,26 |
538,71 |
Novartis Europharm Ltd
|
|
29166.03.01
|
ILARIS INJ.SOL 150MG/ML BTx1VIAL
|
|
8.950,04 |
9.954,29 |
10.762,58 |
Novartis Europharm Ltd
|
|
29166.01.01
|
ILARIS PD.INJ.SOL 150MG BTx1VIAL
|
|
9.297,91 |
10.341,20 |
11.919,27 |
Novartis Europharm Ltd
|
|
30362.04.03
|
JAKAVI TAB 10MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE)
|
|
2.482,45 |
2.760,99 |
2.992,50 |
Novartis Europharm Ltd
|
|
30362.02.03
|
JAKAVI TAB 15MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu)
|
|
2.451,16 |
2.726,20 |
2.962,02 |
Novartis Europharm Ltd
|
|
30362.03.03
|
JAKAVI TAB 20MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu)
|
|
2.451,16 |
2.726,20 |
2.962,02 |
Novartis Europharm Ltd
|
|
30362.01.03
|
JAKAVI TAB 5MG/TAB BT x56 δισκία σε BLISTERS (PVC/PCTFE/Alu)
|
|
1.234,65 |
1.373,18 |
1.517,43 |
Novartis Europharm Ltd
|
|
28673.01.03
|
JALRA F.C.TAB 50mg/tab BTx 28 σε BLISTERS (PA/AL/PVC/AL)
|
|
10,89 |
12,52 |
17,26 |
Novartis Europharm Ltd
|
|
31732.01.01
|
KISQALI F.C.TAB 200MG/TAB BTx21 σε BLISTERS (PCTFE/PVC)
|
|
620,97 |
690,64 |
783,32 |
Novartis Europharm Ltd
|
|
31732.01.03
|
KISQALI F.C.TAB 200MG/TAB BTx42 σε BLISTERS (PCTFE/PVC)
|
|
1.205,61 |
1.340,89 |
1.481,75 |
Novartis Europharm Ltd
|
|
31732.01.05
|
KISQALI F.C.TAB 200MG/TAB BTx63 σε BLISTERS (PCTFE/PVC)
|
|
1.955,68 |
2.175,13 |
2.374,80 |
Novartis Europharm Ltd
|
|
31968.01.01
|
KYMRIAH DISP.INF 1,2x106-6,0x108 κύτταρα 1 ή περισσότεροι σάκκοι Έγχυσης (από συμπολυμερές αιθυλενοξοικού βινυλίου)
|
|
229.701,58 |
255.475,69 |
276.220,31 |
Novartis Europharm Ltd
|
|
32614.01.01
|
LEQVIO INJ.SOL 284MG/1.5 ML(189MG/ML) 1 PF.SYR x1.5 ml
|
|
1.881,64 |
2.092,78 |
2.284,89 |
Novartis Europharm Ltd
|
|
32614.01.02
|
LEQVIO INJ.SOL 284MG/1.5 ML(189MG/ML) 1 PF.SYR x1.5 ml με βελόνα ασφαλείας
|
|
1.824,95 |
2.029,73 |
2.216,06 |
Novartis Europharm Ltd
|
|
27692.01.04
|
LUCENTIS INJ.SOL 10MG/ML BT x 1 VIAL + 1 διηθητική βελόνη
|
|
397,76 |
442,39 |
511,14 |
Novartis Europharm Ltd
|
|
27692.01.01
|
LUCENTIS INJ.SOL 10MG/ML BT x 1 VIAL +1 filter needle+1 injection needle + 1 syringe +1 filter needle+1 injection needle + 1 syringe
|
|
534,87 |
594,88 |
681,02 |
Novartis Europharm Ltd
|
|
27692.01.02
|
LUCENTIS INJ.SOL 10MG/ML BTx1PF.SYRx0,165ML
|
|
397,76 |
442,39 |
511,14 |
Novartis Europharm Ltd
|
|
32071.01.01
|
LUXTURNA C.SO.S.INJ 5x1000000000000 VG/ML Θύλακας αλουμινίου BTx1 VIAL (συμπύκνωμα)+2 VIALSx1.7 ML SOLV
|
|
308.550,06 |
343.171,50 |
371.037,03 |
Novartis Europharm Ltd
|
|
32320.01.02
|
MAYZENT F.C.TAB 0.25MG/TAB 120 δισκία σε Blisters PA/alu/PVC/Alu
|
|
936,50 |
1.041,58 |
1.159,28 |
Novartis Europharm Ltd
|
|
32320.01.01
|
MAYZENT F.C.TAB 0.25MG/TAB Συσκευασία τιτλοποίησης: 12 δισκία σε Blisters PA/alu/PVC/Alu
|
|
91,35 |
105,00 |
129,11 |
Novartis Europharm Ltd
|
|
32320.03.01
|
MAYZENT F.C.TAB 1MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu
|
|
1.141,52 |
1.269,60 |
1.402,97 |
Novartis Europharm Ltd
|
|
32320.02.01
|
MAYZENT F.C.TAB 2MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu
|
|
1.061,61 |
1.180,73 |
1.314,16 |
Novartis Europharm Ltd
|
|
30850.01.02
|
MEKINIST F.C.TAB 0.5MG/TAB HDPE BOTTLE x 30 TABS
|
|
781,20 |
868,86 |
976,25 |
Novartis Europharm Ltd
|
|
30850.03.02
|
MEKINIST F.C.TAB 2MG/TAB HDPE BOTTLE x 30 TABS
|
|
3.148,16 |
3.501,40 |
3.785,72 |
Novartis Europharm Ltd
|
|
31423.01.01
|
NEPARVIS F.C.TAB (24+26)MG/TAB BTx28 (PVC/PVDC blister)
|
|
45,54 |
52,35 |
66,59 |
Novartis Europharm Ltd
|
|
31423.02.02
|
NEPARVIS F.C.TAB (49+51)MG/TAB BTx56 (PVC/PVDC blister)
|
|
90,96 |
104,55 |
128,56 |
Novartis Europharm Ltd
|
|
31423.03.02
|
NEPARVIS F.C.TAB (97+103)MG/TAB BTx56 (PVC/PVDC blister)
|
|
90,79 |
104,37 |
128,33 |
Novartis Europharm Ltd
|
|
28209.01.01
|
NEVANAC EY.DRO.SUS 1MG/ML BT x 1 BOTTLE (LDPE) x 5 ML
|
|
9,35 |
10,75 |
14,82 |
Novartis Europharm Ltd
|
|
28209.02.01
|
NEVANAC EY.DRO.SUS 3MG/ML BT x 1 BOTTLE (LDPE) x 3 ML x 3 ML
|
|
14,71 |
16,91 |
23,30 |
Novartis Europharm Ltd
|
|
28209.02.02
|
NEVANAC EY.DRO.SUS 3MG/ML BT x 1 LDPE BOTTLE (OVAL) x 3 ML
|
|
14,71 |
16,91 |
23,30 |
Novartis Europharm Ltd
|
|
29268.01.02
|
ONBREZ BREEZHALER INHPD.CAP 150MCG/CAP BTx30 σε BLISTERS (PA/ALU/PVC) + 1 συσκευή εισπνοής
|
|
17,10 |
19,66 |
27,09 |
Novartis Europharm Ltd
|
|
29268.02.02
|
ONBREZ BREEZHALER INHPD.CAP 300MCG/CAP BTx30 σε BLISTERS (PA/ALU/PVC) + 1 συσκευή εισπνοής
|
|
18,64 |
21,43 |
29,53 |
Novartis Europharm Ltd
|
|
25273.01.01
|
OPATANOL EY.DRO.SOL 1MG/ML FLX5ML
|
|
4,05 |
4,68 |
6,70 |
Novartis Europharm Ltd
|
|
32504.01.02
|
PIQRAY F.C.TAB 150MG/TAB 56 δισκία σε blisters (PVC/PCTFE/alu)
|
|
2.413,29 |
2.684,07 |
2.916,24 |
Novartis Europharm Ltd
|
|
32504.03.02
|
PIQRAY F.C.TAB 200MG/TAB 28 δισκία σε blisters (PVC/PCTFE/alu)
|
|
2.413,29 |
2.684,07 |
2.916,24 |
Novartis Europharm Ltd
|
|
32504.02.02
|
PIQRAY F.C.TAB 50MG/TAB + F.C.TAB 200MG/TAB 56 δισκία (28x50MG + 28x200MG) σε blisters (PVC/PCTFE/alu)
|
|
2.413,29 |
2.684,07 |
2.916,24 |
Novartis Europharm Ltd
|
|
29350.01.02
|
REVOLADE F.C.TAB 25MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU)
|
|
636,91 |
708,38 |
799,69 |
Novartis Europharm Ltd
|
|
29350.02.02
|
REVOLADE F.C.TAB 50MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU)
|
|
1.277,87 |
1.421,25 |
1.570,55 |
Novartis Europharm Ltd
|
|
29350.05.01
|
REVOLADE PD.ORA.SUS 25MG/SACHET 30 φακελίσκοι + 1 φιάλη ανάμιξης + 30 σύριγγες μιας χρήσης για χορήγηση από του στόματος + 1 βιδωτό πώμα με δυνατότητα προσαρμογής στη σύριγγα
|
|
778,62 |
865,99 |
973,03 |
Novartis Europharm Ltd
|
|
31746.01.01
|
RYDAPT SOFT.CAPS 25MG/CAP BTx112 καψάκια (4 BLIST x28) καψάκια σε BLISTERS PA/Al/PVC-Al)
|
|
9.760,27 |
10.855,43 |
11.736,89 |
Novartis Europharm Ltd
|
|
33143.01.02
|
SCEMBLIX F.C.TAB 20MG/TAB BTx 60 ΔΙΣΚΙΑ σε BLISTERS (PCTFE/PVC/ALU)
|
|
3.664,59 |
4.075,78 |
4.406,74 |
Novartis Europharm Ltd
|
|
33143.02.02
|
SCEMBLIX F.C.TAB 40MG/TAB BTx 60 ΔΙΣΚΙΑ σε BLISTERS (PCTFE/PVC/ALU)
|
|
3.664,59 |
4.075,78 |
4.406,74 |
Novartis Europharm Ltd
|
|
27817.01.01
|
SEBIVO F.C.TAB 600 MG/TAB BT x 28 σε BLISTERS (PVC/ALU) (PVC/ALU)
|
|
299,21 |
332,79 |
388,03 |
Novartis Europharm Ltd
|
|
30386.01.03
|
SEEBRI BREEZHALER INHPD.CAP 50mcg/CAP ή 44mcg/DOSE BTx30x1 καψάκιο σε BLIST (alu/alu) + 1 συσκευή εισπνοής
|
|
16,44 |
18,90 |
26,04 |
Novartis Europharm Ltd
|
|
30883.01.01
|
SIMBRINZA EY.DRO.SUS (10+2)MG/ML 1BTx1 BOTTLE x5ML
|
|
7,77 |
8,92 |
12,30 |
Novartis Europharm Ltd
|
|
23884.03.01
|
SIMULECT PD.I.S.INF 20MG/VIAL BT X 1 VIAL
|
|
714,45 |
794,61 |
897,04 |
Novartis Europharm Ltd
|
|
23884.01.01
|
SIMULECT PS.SOL.INF 20MG/VIAL BTX1VIAL+1AMP SOLV
|
|
714,45 |
794,61 |
897,04 |
Novartis Europharm Ltd
|
|
24820.02.05
|
STARLIX F.C.TAB 120MG/TAB BTX84
|
|
19,28 |
22,17 |
30,55 |
Novartis Europharm Ltd
|
|
24820.03.05
|
STARLIX F.C.TAB 180MG/TAB BTX84
|
|
19,98 |
22,96 |
31,64 |
Novartis Europharm Ltd
|
|
24820.01.05
|
STARLIX F.C.TAB 60MG/TAB BTX84
|
|
18,88 |
21,70 |
29,90 |
Novartis Europharm Ltd
|
|
33101.01.02
|
TABRECTA F.C.TAB 150MG/TAB BTx 120 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
6.798,87 |
7.561,75 |
8.175,76 |
Novartis Europharm Ltd
|
|
33101.02.02
|
TABRECTA F.C.TAB 200MG/TAB BTx 120 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
6.798,87 |
7.561,75 |
8.175,76 |
Novartis Europharm Ltd
|
|
30590.01.01
|
TAFINLAR CAPS 50MG/CAP BTx28 (HDPE Bottle)
|
|
747,77 |
831,67 |
934,46 |
Novartis Europharm Ltd
|
|
30590.02.01
|
TAFINLAR CAPS 75MG/CAP BTx28 (HDPE Bottle)
|
|
1.022,89 |
1.137,66 |
1.266,21 |
Novartis Europharm Ltd
|
|
28169.02.02
|
TASIGNA CAPS 150MG/CAP BTx112 σε BLIST (PVC/PVDC/AL)
|
|
1.715,53 |
1.908,03 |
2.088,24 |
Novartis Europharm Ltd
|
|
28169.01.06
|
TASIGNA CAPS 200MG/CAP BLISTx112 (PVC/PVDC/AL) σε χάρτινο κουτί
|
|
2.287,35 |
2.544,00 |
2.764,06 |
Novartis Europharm Ltd
|
|
28169.01.03
|
TASIGNA CAPS 200MG/CAP BT x 112 σε BLIST (PVC/PVDC/AL) (PVC/PVDC/AL)
|
|
2.446,60 |
2.721,12 |
2.956,50 |
Novartis Europharm Ltd
|
|
30387.01.03
|
TOVANOR BREEZHALER INHPD.CAP 50mcg/CAP ή 44mcg/DOSE BTx30x1 καψάκιο σε BLIST (alu/alu) + 1 συσκευή εισπνοής
|
|
16,44 |
18,90 |
26,04 |
Novartis Europharm Ltd
|
|
25115.01.03
|
TRAVATAN EY.DRO.SOL 40MC/ML BTx1 BOTTLE (LDPE) x 2,5ML
|
|
3,69 |
4,24 |
5,84 |
Novartis Europharm Ltd
|
|
25115.01.01
|
TRAVATAN EY.DRO.SOL 40MC/ML FLX2,5ML
|
|
5,21 |
5,99 |
8,26 |
Novartis Europharm Ltd
|
|
28371.01.04
|
TYVERB F.C.TAB 250MG/TAB BOTTLE (HDPE)x70
|
|
732,53 |
814,73 |
915,43 |
Novartis Europharm Ltd
|
|
30618.01.03
|
ULTIBRO BREEZHALER INHPD.CAP (85+43)MCG/DOSE[(110+50)MCG/CAP] BTx30 (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής
|
|
26,84 |
30,85 |
42,52 |
Novartis Europharm Ltd
|
|
29500.01.02
|
VOTRIENT F.C.TAB 200MG/TAB 1 BOTTLE (HDPE) x 90
|
|
1.642,68 |
1.826,99 |
1.999,55 |
Novartis Europharm Ltd
|
|
29500.02.02
|
VOTRIENT F.C.TAB 400MG/TAB 1 BOTTLE (HDPE) x 60
|
|
2.091,00 |
2.325,62 |
2.532,94 |
Novartis Europharm Ltd
|
|
30020.04.02
|
VOTUBIA DISP.TAB 2MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
597,42 |
664,46 |
753,63 |
Novartis Europharm Ltd
|
|
30020.05.01
|
VOTUBIA DISP.TAB 3MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
1.030,84 |
1.146,50 |
1.276,06 |
Novartis Europharm Ltd
|
|
30020.06.01
|
VOTUBIA DISP.TAB 5MG/TAB BTx30 σε κυψέλη (alu/PA/alu/PVC)
|
|
1.493,54 |
1.661,13 |
1.826,83 |
Novartis Europharm Ltd
|
|
30020.03.01
|
VOTUBIA TAB 10MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
2.085,49 |
2.319,50 |
2.526,29 |
Novartis Europharm Ltd
|
|
30020.01.02
|
VOTUBIA TAB 2,5MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
746,77 |
830,56 |
933,21 |
Novartis Europharm Ltd
|
|
30020.02.01
|
VOTUBIA TAB 5MG/TAB BTx30 σε BLISTERS (alu/PA/alu/PVC)
|
|
1.449,25 |
1.611,86 |
1.772,64 |
Novartis Europharm Ltd
|
|
24992.04.08
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BT X 1 PF. PEN (1ML)
|
|
215,35 |
239,50 |
284,33 |
Novartis Europharm Ltd
|
|
24992.04.05
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BT X 1 PF. SYR (1ML) + 1 NEEDLE (27 GAUGE)
|
|
215,35 |
239,50 |
284,33 |
Novartis Europharm Ltd
|
|
24992.04.01
|
XOLAIR INJ.SOL 150MG/1,0ML PF.SYR BTx1 PF. SYR x1,0ML
|
|
215,35 |
239,50 |
284,33 |
Novartis Europharm Ltd
|
|
24992.05.04
|
XOLAIR INJ.SOL 300MG/2ML BT X 1 PF. PEN (2.0ML)
|
|
429,55 |
477,75 |
552,00 |
Novartis Europharm Ltd
|
|
24992.03.07
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BT X 1 PF. PEN (0,5ML)
|
|
89,22 |
102,56 |
126,11 |
Novartis Europharm Ltd
|
|
24992.03.04
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BT X 1 PF. SYR (0,5ML) + 1 NEEDLE (27 GAUGE)
|
|
89,22 |
102,56 |
126,11 |
Novartis Europharm Ltd
|
|
24992.03.01
|
XOLAIR INJ.SOL 75MG/0,5ML PF.SYR BTx1 PF. SYR x0,5ML
|
|
96,32 |
110,71 |
136,13 |
Novartis Europharm Ltd
|
|
30619.01.03
|
XOTERNA BREEZHALER INHPD.CAP (85+43)MCG/DOSE [110+50)MCG/CAP] BTx30 (PA/Alu/PVC-Alu) blisters x1 CAP + 1 συσκευή εισπνοής
|
|
26,84 |
30,85 |
42,52 |
Novartis Europharm Ltd
|
|
32485.01.02
|
ZIMBUS BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
32485.01.03
|
ZIMBUS BREEZHALER INHPD.CAP (114+46+136)MCG/DOSE [(150+50+160) MCG/CAP] 30x1 καψάκια σε Blisters (PA/Alu/PVC/Alu-μονάδα δόσης + 1 συσκευή εισπνοής+1 αισθητήρας
|
|
36,15 |
41,55 |
57,26 |
Novartis Europharm Ltd
|
|
32519.01.27
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 10 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.30
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 11 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.33
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 12 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.36
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 13 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.03
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 2 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.06
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 3 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.09
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 4 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.12
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 5 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.15
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 6 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.18
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 7 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.21
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 8 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.24
|
ZOLGENSMA SOL.INF 2x1013vg/ml 1 VIAL x5.5 ml + 9 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.25
|
ZOLGENSMA SOL.INF 2x1013vg/ml 10 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.28
|
ZOLGENSMA SOL.INF 2x1013vg/ml 11 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.31
|
ZOLGENSMA SOL.INF 2x1013vg/ml 12 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.34
|
ZOLGENSMA SOL.INF 2x1013vg/ml 13 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.37
|
ZOLGENSMA SOL.INF 2x1013vg/ml 14 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.02
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 1 VIAL x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.29
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 10 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.32
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 11 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.35
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 12 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.05
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 2 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.08
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 3 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.11
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 4 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.14
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 5 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.17
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 6 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.20
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 7 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.23
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 8 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.26
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x5.5 ml + 9 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.01
|
ZOLGENSMA SOL.INF 2x1013vg/ml 2 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.04
|
ZOLGENSMA SOL.INF 2x1013vg/ml 3 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.07
|
ZOLGENSMA SOL.INF 2x1013vg/ml 4 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.10
|
ZOLGENSMA SOL.INF 2x1013vg/ml 5 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.13
|
ZOLGENSMA SOL.INF 2x1013vg/ml 6 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.16
|
ZOLGENSMA SOL.INF 2x1013vg/ml 7 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.19
|
ZOLGENSMA SOL.INF 2x1013vg/ml 8 VIALS x8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
32519.01.22
|
ZOLGENSMA SOL.INF 2x1013vg/ml 9 VIALS x 8.3 ml
|
|
1.535.203,55 |
1.707.463,96 |
1.846.110,03 |
Novartis Europharm Ltd
|
|
28674.02.12
|
ZOMARIST F.C.TAB (50+1000)mg/tab BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
22,45 |
25,81 |
35,56 |
Novartis Europharm Ltd
|
|
28674.02.03
|
ZOMARIST F.C.TAB (50+1000)mg/tab BTx 60 σε BLISTERS (PA/AL/PVC/AL)
|
|
16,25 |
18,68 |
25,74 |
Novartis Europharm Ltd
|
|
28674.01.12
|
ZOMARIST F.C.TAB (50+850)mg/tab BTx 60 δισκία σε BLISTERS (PCTFE/PVC/ALU)
|
|
30,56 |
35,13 |
48,41 |
Novartis Europharm Ltd
|
|
28674.01.03
|
ZOMARIST F.C.TAB (50+850)mg/tab BTx 60 σε BLISTERS (PA/AL/PVC/AL)
|
|
21,26 |
24,44 |
33,68 |
Novartis Europharm Ltd
|
|
31213.01.01
|
ZYKADIA CAPS 150MG/CAP BTx150 (3x50) σε PVC/PCTFE/Alu blister (πολυσυσκευασία)
|
|
3.720,32 |
4.137,76 |
4.473,75 |
Novartis Europharm Ltd
|
